The most common side effects of Victoza may include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation
Our peptide treatment for weight loss in Johnson City combines the latest advances in regenerative medicine with proven metabolic therapies
GLP-1 agonists (like Ozempic and Mounjaro) reduced asthma symptoms in obese people according to a new study published in Advances in Therapy
Introduction As the popularity of GLP-1 drugs for weight loss soared, the Food and Drug Administration (FDA) began announcing that FDA-approved versions of various GLP-1 drugs were going into shortage, starting with semaglutide (the active ingredient in Wegovy and Ozempic) in March 2022
Semaglutide and tirzepatide offer convenient weekly dosing
Participants were randomly assigned to receive either a once-weekly subcutaneous semaglutide or a placebo for 68 weeks in combination with lifestyle intervention